Dr Jane Osbourn, Vice-President of Research and Development at AstraZeneca and Chair of the UK BioIndustry Association (BIA) has been made an Officer of the Order of the British Empire (OBE) in the Queen’s birthday honours list.
Today, 4 June, sees the unveiling of the UK’s newest life sciences asset, Health Innovation Research Alliance Northern Ireland (HIRANI) at a BIO reception in Philadelphia hosted by the UK Department for International Trade, Invest Northern Ireland, the Welsh Government, BIA, AstraZeneca and the British American Business Council of Greater Philadelphia. It will be followed by a formal launch event on 5 June at the Union League of Philadelphia from 08:30-10:00 EST.
In a ruling handed down today (27 March) by the UK Supreme Court, Lord Hodge has confirmed that discoveries made through well-established or routine research protocols can be inventive and rewarded with a patent
The Government last night committed to further consultation with the BIA on the UK’s future Intellectual Property rights regime in the event of a ‘no deal’ Brexit following concerns raised in the House of Lords.
New figures published today (Thursday 24 January 2019) by the UK BioIndustry Association (BIA) and Informa Pharma Intelligence reveal that the UK biotech sector raised a record £2.2 billion from investors in 2018. The total is the best ever recorded by the trade association and almost double that raised in 2017.
The data is presented in the report Confident capital: backing UK biotech and launched by the Exchequer Secretary to the Treasury, Robert Jenrick MP, at the BIA's Strategic Technologies event in central London today.
Steve Bates OBE, CEO of the BIA said:
“It’s great to see the UK government and NHS committed to exploring a new payment model for antibiotics in our market. The UK took a lead in putting Anti Microbial Resistance (AMR) on the global agenda and it’s really good to see it taking a first mover advantage on innovative pricing and reimbursement for AMR.